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Abstract
Background: This study assessed the associations between nine differentially methylated regions (DMRs) of
imprinted genes in DNA derived from umbilical cord blood leukocytes in males and females and (1) birth weight
for gestational age z score, (2) weight-for-length (WFL) z score at 1 year, and (3) body mass index (BMI) z score at
3 years.
Methods: We conducted multiple linear regression in n = 567 infants at birth, n = 288 children at 1 year, and n = 294
children at 3 years from the Newborn Epigenetics Study (NEST). We stratified by sex and adjusted for race/ethnicity,
maternal education, maternal pre-pregnancy BMI, prenatal smoking, maternal age, gestational age, and paternal race.
We also conducted analysis restricting to infants not born small for gestational age.
Results: We found an association between higher methylation of the sequences regulating paternally expressed gene
10 (PEG10) and anthropometric z scores at 1 year (β = 0.84; 95% CI = 0.34, 1.33; p = 0.001) and 3 years (β = 1.03; 95%
CI = 0.37, 1.69; p value = 0.003) in males only. Higher methylation of the DMR regulating mesoderm-specific transcript
(MEST) was associated with lower anthropometric z scores in females at 1 year (β = − 1.03; 95% CI − 1.60, − 0.45;
p value = 0.001) and 3 years (β = − 1.11; 95% CI − 1.98, − 0.24; p value = 0.01). These associations persisted when
we restricted to infants not born small for gestational age.
Conclusion: Our data support a sex-specific association between altered methylation and weight status in early
life. These methylation marks can contribute to the compendium of epigenetically regulated regions detectable
at birth, influencing obesity in childhood. Larger studies are required to confirm these findings.
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Background
Understanding factors that influence the risk of obesity
in children is crucial to the development of new strat-
egies for obesity prevention. Obesity in early childhood
is a risk factor for obesity later in life [1–3] and for a
number of chronic diseases in both childhood [4] and
adulthood [5]. Birth weight has been associated with
weight outcomes later in life, particularly for those who
are on the extremes of the birth weight distribution
[6–9]. Early identification of obesity or its risk factors
will inform interventions to prevent the progression of
obesity and its consequences later in life [10]. Consistent
with the developmental origins of disease hypothesis, the
intrauterine environment is hypothesized to influence an
individual’s later susceptibility for chronic diseases [11],
including obesity [12, 13].
Epigenetic modifications have been proposed as a
mechanism for the in utero origin of later obesity, and a
growing literature has found supporting evidence
[14–16]. DNA methylation is the most studied epigen-
etic mechanism in humans, due in part, to its stability.
DNA methylation that controls the monoallelic expres-
sion of imprinted genes is established during gametogen-
esis and is stably maintained throughout somatic
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division [17–21] and therefore provides a stable “regis-
ter” of early in utero exposures. A study of famine survi-
vors found that adults who experienced famine in utero
had hypo-methylation of the imprinted IGF2 gene com-
pared to their same sex siblings who had not experi-
enced famine in utero [22]. The significance of this locus
was reported to not have been replicated in this cohort
using alternate techniques, including RRBS. However,
this technique is generally biased toward CG-rich areas
and may not have covered the specific and limited num-
ber of CpGs that comprise the IGF2 DMR. Additional
genes, such as INSR and CPT1A, have also been identi-
fied in association with exposure to the Dutch famine
[23]. Another study found that maternal nutrition, af-
fected by striking seasonal variations in food intake in
the Gambia, influenced methylation at RBM46 [24]. A
colorectal cancer study found that methylation status of
the IGF2/H19 imprinted locus of adult controls was
maintained 3 years later [25]. Moreover, a study of NEST
children between birth and age 1 year found similar re-
sults at the IGF2/H19 locus [26].
Select imprinted genes have been identified as playing
a role in the development of fetal over and undergrowth
caused by imprinting defects. The IGF2 locus is used in
clinical diagnostic settings to identify Beckwith-Wiede-
mann syndrome, which is characterized by overgrowth
[27], and the H19 locus has been used in the diagnosis
of Silver-Russell syndrome (SRS), which is characterized
by undergrowth [28].
Although epigenetic data linking DNA methylation and
childhood obesity has increased exponentially in the last
5 years [29, 30], few regions agnostically identified have
been replicated. This could be in part due to differences in
the ethnic composition; however, differences could also be
due to the sex composition. At imprinted loci, weight has
been associated with the IGF2 locus. Studies have found a
relationship between the IGF2 domain and fetal growth
[31–34] and children’s body composition or weight [32,
35, 36]. Data with directional consistency in associations
between additional differentially methylated regions
(DMRs) and weight gain are required.
This study aims to assess the association between
methylation at nine DMRs of imprinted genes and birth
weight for gestational age (BW/GA) z score, weight-for-
length (WFL) z score at 1 year, and BMI z score at
3 years. In this analysis, we include the following DMRs:
MEG3 and MEG3-IG, which are involved in regulating
the delta-like 1 homolog/maternally expressed gene 3
imprinted domain on chromosome 14q32.2; IGF2 and
H19, which are involved in the imprinting of the insulin
growth factor 2/H19 domain on chromosome 11p15,
which are located upstream of the imprinted promoters
of IGF2 and at the imprinting control region for the
IGF2/H19 imprinted domain near the H19 promoter,
respectively; PLAGL1 at the pleiomorphic adenoma
gene-like 1 locus at 6q24.2; MEST at the
mesoderm-specific transcript promoter at 7q32.2; NNAT
at the neuronatin locus at 20q11.23; PEG3 at the pater-
nally expressed gene 3 promoter region at 19q13.43; and
PEG10 at the epsilon sarcoglycan and paternally
expressed gene 10 promoter region at 7q21.3. We se-
lected these regions for their association with infant and
child growth [32, 34, 37], chronic disease [22, 38], and
parental obesity [39].
Methods
Study sample and data collection
We included data from mothers and children in the
Newborn Epigenetic Study (NEST). We have described
recruitment and enrollment strategies in detail elsewhere
[40]. Briefly, between 2009 and 2011, we recruited
women from five prenatal clinics and obstetric facilities
in Durham, North Carolina. Eligibility criteria included
being at least 18 years of age and intention to use one of
the qualifying obstetric facilities for delivery. We ex-
cluded women if they planned to relinquish custody of
the child or planned to move away from the area in the
following 3 years. We obtained written informed consent
from all participating women. Upon enrollment, mothers
completed questionnaires providing information on
sociodemographic factors, lifestyle characteristics, and
anthropometrics. At delivery, study personnel abstracted
birth outcomes from medical records and infant cord
blood specimens were obtained to assess offspring
methylation. At 1 year, we collected data on child an-
thropometrics, feeding, and lifestyle. This study was ap-
proved by the Institutional Review Board at Duke
University Medical Center.
Of the 1700 enrolled, we excluded 396 women for rea-
sons including miscarriage, refusing further participa-
tion, moving away from the area, or delivering at a
hospital not included in the study. We analyzed DNA
methylation data for the first 600 infants in the study.
Infants with analyzed DNA methylation were not signifi-
cantly different than infants whose DNA methylation
had been analyzed with respect to race, maternal educa-
tion, maternal smoking status, maternal pre-pregnancy
BMI, maternal age, or weight at age 1 (data not shown).
Among infants with DNA methylation data, birth
weight and length measurements were available for 594.
At age 1, we used available weight and length measure-
ments for 306 infants, and at age 3, we used available
weight and height measurements for 314 children. We
calculated BW/GA z scores using an international stand-
ard [41]. We classified infants with BW/GA below the
10th percentile as small for gestational age (SGA). We
calculated WFL z scores at age 1 year using WHO stan-
dards for children’s exact age [42]. We then calculated
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BMI z scores at age 3 years using CDC standards [43].
We excluded 7 children with a WFL z score greater than
5 or less than − 5 at age 1 year, and 11 children with a
BMI z score greater than 5 or less than − 5. In addition,
we excluded infants with possible growth disorders or
imprinting defects; therefore, we excluded from analysis
infants with DNA methylation values ± 4 standard devia-
tions from the mean (n = 6). The current study includes
children with available DNA methylation data at birth
on at least one of the nine DMRs of interest, and who
had plausible length and weight measurements at birth
(n = 576), age 1 (n = 288), or age 3 (n = 294). Plausible
weight and length was defined as a measurement that fell
within the SD limits set for the combined WFL or BMI
and that clearly was not a transcript error (e.g., birth
weight being copied onto 1-year weight). In addition, we
conducted supplemental analysis on 166 children who had
non-missing anthropometric values at birth and age 1 and
3 years to assess directional consistency over time.
DNA methylation
Specimen collection and DNA methylation methods
have been described in detail elsewhere [26]. Briefly, we
collected infant cord blood specimens at birth. We col-
lected samples in EDTA-containing vacutainer tubes and
centrifuged using standard protocols to allow for collec-
tion of plasma and buffy coat, with buffy coat used for
DNA extraction (Qiagen; Valencia, CA). We stored spec-
imens at − 80 °C until the time of analysis. We extracted
DNA using Puregene reagents according to the manu-
facturer’s protocol (Qiagen) and assessed quantity and
quality using a Nanodrop 1000 Spectrophotometer
(Thermo Scientific; Wilmington, DE).
We modified infant genomic DNA (800 ng) by treatment
with sodium bisulfite using the EZ DNA Methylation kit
(Zymo Research; Irvine, CA). Bisulfite treatment of de-
natured DNA converts all unmethylated cytosines to
uracils, leaving methylated cytosines unchanged, allow-
ing for quantitative measurement of cytosine methyla-
tion status. We performed pyrosequencing using a
PyroMark Q96 MD pyrosequencer (Qiagen). Pyrose-
quencing assay design, genomic coordinates, assay con-
ditions, and assay validation are described in detail
elsewhere [33]. Briefly, we designed assays to query
established imprinted gene DMRs using the PyroMark
Assay Design Software (Qiagen). We optimized PCR
conditions to produce a single, robust amplification
product. We used defined mixtures of fully methylated
and unmethylated control DNAs to show a linear in-
crease in detection of methylation values as the level of
input DNA methylation increased (Pearson r is 0.99 for
all DMRs). Once we defined optimal conditions, we an-
alyzed each DMR using the same amount of input
DNA from each specimen (40 ng, assuming complete
recovery following bisulfite modification of 800 ng
DNA). We determined percentage of methylation for
each CpG cytosine using Pyro Q-CpG software
(Qiagen). We performed pyrosequencing assays in du-
plicate for all specimens whose values fell more than
two SD above or below the means, in which case we
used the average of the two runs. The values obtained
represent the mean methylation for the CpG sites
contained within the sequence being analyzed
(Additional file 1: Figure S1).
Statistical analysis
We calculated frequencies and means of sociodemo-
graphic variables and conducted multiple linear regression
to test the association between DNA methylation and
early anthropometric outcomes. We determined covari-
ates a priori based on directed acyclic graphs (DAG). We
chose sex as a potential effect measure modifier (EMM),
as DNA methylation has been previously shown to vary
by sex [44, 45]. We tested the following covariates as po-
tential confounders: maternal education (less than a col-
lege degree/college degree or greater), maternal
gestational diabetes (yes/no), maternal pre-pregnancy
BMI, maternal smoking at any time during pregnancy
(yes/no), gestational weight gain, parity (primiparous,
multiparous), maternal age at delivery, gestational age,
paternal race, maternal race, and date of length and
weight measurements relative to child’s birthday. We
tested potential confounders in the model one at a time
and kept variables if they changed the estimate by more
than 10%. Final models included maternal race, mater-
nal education, maternal pre-pregnancy BMI, maternal
smoking, maternal age, gestational age, and paternal
race. As infants who are SGA may have different
growth patterns compared to infants who are average
for gestational age, we conducted supplemental analysis
to determine the effect of excluding infants who were
SGA. We also conducted supplemental analysis includ-
ing maternal alcohol consumption during pregnancy as
a covariate, and an additional supplemental analysis, in
which we stratified by race/ethnicity to determine pos-
sible effect measure modification.
Previously reported Cronbach’s alpha for correlations
among methylation values from all CpGs measured at
each DMR was > 0.89 [40]; therefore, we used mean DNA
methylation values for each DMR. DNA methylation was
assessed in tertiles (low, moderate, high), as both higher
and lower levels of methylation have been associated with
health outcomes, depending on the DMR [39, 40]. Given
the expected 50% methylation of imprinted genes, we used
the mid tertile of methylation as the referent category.
Thus, results represent the child z scores associated with
high or low methylation compared to “moderate”
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methylation. We conducted all statistical analysis using
SAS 9.4 (SAS Institute, Inc., Cary, NC).
Among infants, 37.0% of mothers were African American,
28.3% were White/Caucasian, and 34.7% were of other
races/ethnicities including Hispanic and Asian/Pacific
Islander (Table 1). For the 1-year sample, 37.9% of
mothers were African American, 30.2% were White,
and 31.9% were “other” race. For the 3-year sample,
39.4% of mothers were African American, 28.3% were
White, and 32.3% were of other races and ethnicities.
In all samples, the majority of women in the study
completed less than a college degree (70.8% for new-
borns, 66.4% for age 1 year, and 68.4% for age 3 years)
and reported not smoking at any point during preg-
nancy (83, 85.5, and 85.3% for newborns, age 1, and age
3, respectively). Approximately half of the newborn
sample reported some sort of alcohol consumption in
early pregnancy (50.9%). The mean (SD) maternal age
for women in the birth sample was 28 years (± 5.7).
Mothers in the 1-year sample were on average 28.0 (± 5.8)
years, and those in the 3-year sample were on average
28.1 (± 5.8) years. The mean maternal pre-pregnancy BMI
for women in the birth weight sample was 27.4 (± 7.2),
BMI for mothers in the 1-year sample was 28.0, and BMI
for mothers in the 3-year sample was 28.1 (± 5.8) years.
The mean gestational age for the sample at birth was 38.7
(1.7) weeks. The mean birthweight of infants in the sam-
ple was 3304 g (± 540). There were no significant differ-
ences in the study sample demographic makeup between
children or mothers in the newborn, age 1 year, or age
3 year samples (data not shown). However, women were
more likely to be college educated in the sample of 166
Table 1 Sociodemographic characteristics of study sample
Newborn 1 year 3 years Complete cases
Birth weight (grams), mean (SD) 3304.2 (540.3) – – 3279.8 (621.1)
Child BMI (kg), mean (SD) – 16.4 (2.1) 16.4 (1.9)
Birth weight for gestational age z score, mean (SD) − 0.09 (1.0) – – − 0.01 (0.9)
BMI z score, mean (SD) – – 0.15 (1.3) 0.20 (1.5)
Weight-for-length z score, mean (SD) – 0.83 (1.9) – 0.78 (1.3)
Race, N (%)
Black 213 (37) 109 (37.9) 117 (39.4) 66 (39.8)
White 163 (28.3) 87 (30.2) 84 (28.3) 44 (26.5)
Other 200 (34.7) 92 (31.9) 96 (32.3) 56 (33.7)
Maternal education, N (%)
Less than HS 175 (32.1) 86 (30.1) 87 (29.9) 48 (29.1)
Completed high school 211 (38.7) 104 (36.3) 112 (38.5) 61 (37.0)
Completed college 159 (29.2) 96 (33.6) 92 (31.6) 56 (33.9)
Missing 31 2 6 1
Maternal smoking, N (%)
Yes 91 (17) 41 (14.5) 42 (14.7) 23 (14.2)
No 445 (83) 242 (85.5) 243 (85.3) 139 (85.8)
Missing 40 5 12 4
Maternal alcohol consumption, N (%)
Yes 179 (50.9) 105 (54.4) 98 (51.0) 63 (57.3)
No 173 (49.1) 88 (45.6) 94 (49.0) 64 (42.7)
Missing 224 95 104 56
Maternal age, mean (SD) 27.8 (5.8) 28.0 (5.8) 28.1 (5.8) 27.9 (5.6)
Maternal pre-pregnancy BMI, mean (SD) 27.6 (7.2) 27.1 (6.6) 27.4 (6.9) 27.2 (6.6)
Gestational age 38.7 (1.7) 38.5 (2.0) 38.6 (1.9) 38.7 (2.1)
Infant sex, N (%)
Male 299 (52.1) 149 (51.7) 152 (51.2) 86 (51.8)
Female 275 (47.9) 139 (48.3) 145 (48.8) 80 (48.2)
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complete cases, in which children had anthropometric
data for all 3 time points.
Results
Birth weight and DNA methylation by sex
In girls, we observed a statistically significant association
between high methylation at MEST and greater birth
weight for gestational age (β = 0.45; 95% CI 0.12, 0.78; p
value 0.007; data not shown). However, this association
did not persist after adjustment. We observed no statisti-
cally significant associations between methylation and
birth weight for gestational age z scores in boys.
Weight-for-length z scores at 1 year and DNA methylation
by sex
After adjustment (Table 2), we observed an association be-
tween high PEG10 DMR methylation and greater WFL z
scores at 1 year in boys (β = 0.84; 95% CI 0.34, 1.33;
p value = 0.001). Alternatively, low methylation at IGF2
DMR was associated with a lower WFL z score at 1 year
in boys (β = − 0.63; 95% CI − 1.16, − 0.10; p value = 0.02).
In girls, both low and high methylation at the PLAGL1
DMR (low: β = 0.72; 95% CI − 1.19, − 0.25; p value = 0.003;
high: β = − 0.81; 95% CI − 1.29, − 0.33; p value = 0.0001)
and the MEST DMR (low: β = − 0.99; 95% CI − 1.59,
− 0.39; p value = 0.002; high: β=− 1.03; 95% CI − 1.60, − 0.45;
Table 2 Adjusted results of the association between DNA methylation at birth and birth weight for gestational age z scores, BMI z scores at
age 1 and age 3
Birth weight for gestational age WFL age 1 BMI age 3
Boys Girls Boys Girls Boys Girls
β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
MEG3
Low 0.09 (− 0.23, 0.40) 0.10 (− 0.22, 0.42) − 0.67 (− 1.23, − 0.11) − 0.16 (− 0.70, 0.38) 0.11 (− 0.58, 0.80) − 0.21 (− 1.04, 0.61)
High − 0.05 (− 0.35, 0.26) − 0.26 (− 0.56, 0.04) − 0.79 (− 1.37, − 0.21) − 0.08 (− 0.58, 0.42) 0.05 (− 0.64, 0.74) − 0.29 (− 1.10, 0.52)
PLAGL1
Low 0.20 (− 0.08, 0.49) 0.24 (− 0.06, 0.54) 0.02 (− 0.50, 0.53) − 0.72** (− 1.19, − 0.25) 0.12 (− 0.53, 0.76) 0.39 (− 1.40, 1.19)
High 0.13 (− 0.16, 0.43) 0.14 (− 0.16, 0.44) 0.52 (− 0.003, 1.04) − 0.81** (− 1.29, − 0.33) 0.31 (− 0.32, 0.93) − 0.07 (− 0.81, 0.67)
PEG10
Low − 0.10 (− 0.39, 0.20) 0.31 (− 0.003, 0.63) 0.20 (− 0.31, 0.71) − 0.03 (− 0.59, 0.52) 0.32 (− 0.32, 0.95) 0.14 (− 0.70, 0.97)
High 0.01 (− 0.31, 0.32) 0.09 (− 0.24, 0.43) 0.84** (0.34, 1.33) 0.03 (− 0.51, 0.58) 1.03** (0.37, 1.69) 0.04 (− 0.82, 0.89)
IGF2
Low − 0.15 (− 0.46, 0.16) 0.40 (0.08, 0.72) − 0.63* (− 1.16, − 0.10) 0.24 (− 0.28, 0.75) − 0.12 (− 0.76, 0.52) − 0.10 (− 0.87, 0.66)
High 0.06 (− 0.26, 0.38) 0.21 (− 0.11, 0.53) − 0.21 (− 0.73, 0.31) − 0.03 (− 0.53, 0.48) − 0.14 (− 0.80, 0.52) − 0.61 (− 1.39, 0.18)
MEST
Low 0.04 (− 0.27, 0.34) 0.21 (− 0.12, 0.34) 0.07 (− 0.47, 0.61) − 0.99** (− 1.59, − 0.39) 0.26 (− 0.43, 0.94) − 0.41 (− 1.28, 0.45)
High − 0.04 (− 0.26, 0.38) 0.38 (0.04, 0.72) 0.32 (− 0.23, 0.86) − 1.03** (− 1.60, − 0.45) 0.08 (− 0.63, 0.79) − 1.11* (− 1.98, − 0.24)
MEG3-IG
Low − 0.01 (− 0.31, 0.34) − 0.07 (− 0.41, 0.27) 0.09 (− 0.47, 0.65) − 0.56 (− 1.13, 0.02) − 0.24(− 0.92, 0.45) − 0.62 (− 1.44, 0.21)
High − 0.31 (− 0.66, 0.05) − 0.08 (− 0.42, 0.26) − 0.44 (− 1.00, 0.12) − 0.30 (− 0.83, 0.23) − 0.10 (− 0.87, 0.67) − 0.80 (− 1.68, 0.08)
H19
Low 0.29 (−0.04, 0.62) 0.04 (− 0.26, 0.35) 0.26 (− 0.29, 0.80) − 0.13 (− 0.63, 0.37) 0.24 (− 0.48, 0.96) 0.09 (− 0.73, 0.90)
High 0.03 (− 0.30, 0.36) 0.22 (− 0.09, 0.54) 0.29 (− 0.25, 0.82) − 0.51 (− 1.02, 0.01) 0.39 (− 0.30, 1.09) 0.34 (− 0.50, 1.19)
NNAT
Low − 0.06 (− 0.40, 0.28) − 0.07 (− 0.41, 0.28) − 0.28 (− 0.89, 0.34) 0.24 (− 0.25, 0.72) − 0.26 (− 1.00, 0.48) 1.52** (0.69, 2.34)
High − 0.07 (− 0.42, 0.27) 0.16 (− 0.18, 0.50) − 0.10 (− 0.69, 0.48) 0.26 (− 0.26, 0.79) − 0.14 (− 0.82, 0.54) 0.55 (− 0.27, 1.37)
PEG3
Low 0.09 (− 0.19, 0.38) − 0.09 (− 0.41, 0.23) − 0.15 (− 0.72, 0.42) − 0.29 (− 0.84, 0.26) 0.41 (− 0.23, 1.05) − 0.95* (− 1.80, − 0.10)
High 0.06 (− 0.25, 0.38) − 0.15 (− 0.48, 0.18) − 0.20 (− 0.76, 0.37) − 0.48 (− 1.02, 0.06) − 0.18 (− 0.91, 0.55) − 0.46 (− 1.35, 0.44)
Adjusted for maternal and paternal race, maternal education, maternal smoking, maternal pre-pregnancy BMI, maternal age, and gestational age. DNA methylation measured
in tertiles, comparing low and high methylation to moderate methylation
*p < 0.05. **Statistically significant after Bonferroni correction (p < 0.006)
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p value = 0.001) were associated with lower WFL z
scores at age 1 year after adjustment (Fig. 1).
BMI z scores at 3 years and DNA methylation by sex
At age 3 years, the association between high methylation
at the PEG10 DMR and greater anthropometric z score
persisted after adjustment in boys (β = 1.03; 95% CI 0.37,
1.69; p value 0.003). In girls, the association between high
methylation at the MEST DMR and lower anthropometric
z score also persisted after adjustment (β = − 1.11; 95%CI
− 1.98, − 0.24; p value 0.01). In addition, we observed an
association between low methylation at the PEG3 DMR
and lower BMI z score at 3 years after adjustment in girls
(β = − 0.95; 95% CI − 1.80, − 0.10; p value = 0.03).
Analysis excluding SGA infants
When excluding SGA infants (n = 69 at birth, n = 31 at
1 year, n = 27 at 3 years), additional associations emerged at
the MEST DMR at birth and the MEG3, H19, and NNAT
DMRs at 1 year of age (data not shown). High methylation
at the MEST DMR was associated with a greater BW/GA z
score in girls (β = 0.32; 95% CI 0.009, 0.63; p value = 0.04).
At 1 year, high and low methylation at the MEG3 DMR
were associated with a lower WFL z score in boys
(low: β = − 0.81; 95% CI − 1.44, − 0.18; p value = 0.01;
high: β = − 0.91; 95% CI − 1.57, − 0.25; p value = 0.008). In
girls, high methylation at the H19 DMR was also associ-
ated with a lower WFL z score (β = − 0.58; 95% CI − 1.15,
− 0.008; p value = 0.047), and lower methylation at the
NNAT DMR was associated with a greater WFL z score
(β = 0.63; 95% CI 0.13, 1.13; p value = 0.02). All other asso-
ciations, with the exception of the association between
low methylation at the IGF2 DMR and a lower WFL z
score at 1 year, persisted after exclusion of SGA infants.
Analysis including maternal alcohol consumption as a
covariate
We conducted additional analyses, in which we included
maternal alcohol consumption during early pregnancy as
a covariate. We found that all associations between
methylation and WFL z scores at 1 year remained
statistically significant compared to our main analysis
(data not shown). Additionally, we observed an associ-
ation between low IGF2 methylation and greater birth
weight for gestational age z score in girls (β = 0.53; 95%
CI 0.13, 0.93; p value = 0.01) and an association between
both low and high MEST DMR methylation and lower
BMI z scores at 3 years in girls (low: β = − 1.31; 95%
CI − 2.46, − 0.15; p value = 0.03; high: β = − 1.40; 95%
CI − 2.51, − 0.29; p value = 0.01).
Analysis stratified by race/ethnicity
Additionally, we conducted supplemental stratified ana-
lyses to see if there were differences by race/ethnicity, as
previous studies have found differential methylation in as-
sociation with race/ethnicity. The only statistically signifi-
cant association we observed was between low
methylation at the MEST DMR and greater birth weight
for gestational z scores among Blacks (β = 0.54; 95% CI
0.09, 0.99; p value = 0.02—data not shown). At year 1, we
found an association between high PEG10 DMR methyla-
tion and greater WFL z scores among Blacks and Whites
(Blacks: β = 0.69; 95% CI 0.12, 1.27; p value = 0.02; Whites:
β = 0.66; 95% CI 0.11, 1.21; p value = 0.02). We also found
an association between high MEG3-IG DMR methylation
Fig. 1 Association between select DMR methylation and BW/GA z scores, WFL z scores age 1 year, and BMI z scores age 3 years. Comparison of
girls vs. boys at PEG10, NNAT, and MEST DMRs
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and lower WFL z scores among Whites (β = − 0.64; 95%
CI − 1.25, − 0.03; p value = 0.04). At 3 years, we found an
association between low MEG3-IG DMR methylation and
lower BMI z scores among Blacks (β = − 0.76; 95%
CI − 1.48, − 0.05; p value = 0.04). An association was
also observed between low NNAT DMR methylation
and greater BMI z scores among Blacks (β = 0.99;
95% CI 0.14, 1.84; p value = 0.02).
Complete case analysis
Supplemental analysis on the 166 infants (n = 15 SGA
children) who had non-missing anthropometric data for
all 3 time points showed directional consistency in all
associations. However, not all associations remained sta-
tistically significant in the smaller sample (Table 3). In
girls, the association between high methylation at the
PLAGL1 DMR and lower WFL z scores remained
statistically significant (β = − 0.82; 95% CI − 1.51, − 0.12;
p value = 0.02), as did the associations between low and
high methylation at the MEST DMR and WFL z scores
(low: β = − 1.18; 95% CI − 2.04, − 32; p value = 0.009;
high: β = − 1.57; 95% CI − 2.4, − 0.73; p value = 0.0004).
At 3 years in boys, the association between high PEG10
DMR methylation and greater BMI z scores remained
statistically significant (β = 1.25; 95% CI 0.38, 2.12;
p value = 0.006). In girls, the association between lower
PEG3 DMR methylation and lower BMI z scores at 3 years
also remained statistically significant (β = − 1.30; 95%
CI − 2.34, 0.26; p value = 0.02). Notably, additional
statistically significant associations were observed
Table 3 Supplemental analysis: complete cases: adjusted regression of DNA methylation at birth and anthropometric z scores
BW/GA WFL z scores 1 year BMI z scores 3 years
Boys Girls Boys Girls Boys Girls
β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
MEG3
Low 0.46 (− 0.08, 0.10) 0.23 (− 0.43, 0.85) − 0.73 (− 1.56, 0.09) 0.01 (− 0.69, 0.71) − 0.22 (− 1.26, 0.83) 0.24 (− 0.79, 1.27)
High 0.04 (− 0.53, 0.60) − 0.02 (− 0.68, 0.63) − 0.87 (− 1.73, 0.00) 0.47 (− 0.25, 1.18) − 0.10 (− 1.20, 0.99) − 0.17 (− 1.22, 0.87)
PLAGL1
Low 0.20 (− 0.29, 0.70) 0.30 (− 0.30, 0.89) − 0.13 (− 0.89, 0.64) − 0.46 (− 1.17, 0.25) 0.07 (− 0.82, 0.97) − 0.04 (− 1.01, 0.94)
High 0.26 (− 0.24, 0.76) 0.13 (− 0.44, 0.71) 0.22 (− 0.53, 0.97) − 0.82* (− 1.51, − 0.12) 0.82 (− 0.06, 1.70) 0.05 (− 0.90, 1.00)
PEG10
Low − 0.35 (− 0.86, 0.16) 0.40 (− 0.21, 1.00) 0.06 (− 0.77, 0.88) 0.11 (− 0.69, 0.90) 0.53 (− 0.39, 1.46) 0.54 (− 0.47, 1.56)
High 0.03 (− 0.44, 0.50) 0.63* (0.07, 1.19) 0.65 (− 0.12, 1.42) 0.01 (− 0.73, 0.74) 1.25* (0.38, 2.12) 0.64 (− 0.31, 1.58)
IGF2
Low − 0.46 (− 1.02, 0.10) 0.21 (− 0.37, 0.78) − 0.51 (− 1.27, 0.25) 0.30 (− 0.46, 1.06) − 0.40 (− 1.35, 0.55) 0.40 (− 0.58, 1.38)
High − 0.17 (− 0.70, 0.36) 0.58* (0.03, 1.12) − 0.02 (− 0.73, 0.68) − 0.28 (− 0.99, 0.43) − 0.36 (− 1.25, 0.53) − 0.25 (− 1.17, 0.66)
MEST
Low 0.41 (− 0.13, 0.95) − 0.17 (− 0.85, 0.50) 0.20 (− 0.58, 0.99) − 1.18* (− 2.03, − 0.32) 0.03 (− 0.98, 1.05) − 0.36 (− 1.57, 0.86)
High − 0.05 (− 0.56, 0.47) 0.62 (− 0.04, 1.28) 0.38 (− 0.37, 1.12) − 1.57** (− 2.41, − 0.74) − 0.14 (− 1.11, 0.82) − 1.09 (− 2.27, 0.08)
MEG3-IG
Low − 0.10 (− 0.59, 0.39) − 0.58 (− 1.30, 0.13) − 0.22 (− 0.98, 0.55) − 0.14 (− 1.03, 0.75) − 0.60 (− 1.56, 0.36) − 0.15 (− 1.08, 0.78)
High − 0.77* (− 1.29, − 0.24) − 0.10 (− 0.77, 0.56) − 0.70 (− 1.52, 0.12) − 0.16 (− 0.98, 0.67) − 0.19 (− 1.22, 0.83) − 0.59 (− 1.46, 0.27)
H19
Low 0.21 (− 0.32, 0.73) − 0.28 (− 0.86, 0.31) − 0.001 (− 0.77, 0.77) 0.24 (− 0.53, 1.01) 0.53 (− 0.39, 1.46) 0.06 (− 0.97, 1.06)
High 0.01 (− 0.52, 0.53) 0.23 (− 0.33, 0.79) − 0.001 (− 0.75, 0.75) − 0.41 (− 1.13, 0.32) 0.45 (− 0.45, 1.35) − 0.08 (− 1.05, 0.89)
NNAT
Low 0.07 (− 0.48, 0.61) − 0.41 (− 1.02, 0.20) − 0.89* (− 1.68, − 0.09) 0.47 (− 0.18, 1.13) − 0.59 (− 1.60, 0.42) 1.12* (0.09, 2.15)
High − 0.26 (− 0.76, 0.24) 0.39 (− 0.30, 1.08) − 0.53 (− 1.27, 0.22) 0.39 (− 0.34, 1.12) − 0.31 (− 1.25, 0.63) 0.24 (− 0.91, 1.38)
PEG3
Low 0.03 (− 0.52, 0.58) 0.16 (− 0.46, 0.78) − 0.22 (− 1.07, 0.62) 0.00 (− 0.81, 0.81) 0.46 (− 0.48, 1.40) − 1.30* (− 2.34, − 0.25)
High 0.06 (− 0.54, 0.65) 0.42 (− 0.20, 1.04) − 0.26 (− 1.17, 0.66) − 0.30 (− 1.12, 0.52) − 0.31 (− 1.33, 0.71) − 0.86 (− 1.91, 0.20)
Adjusted for maternal and paternal race, maternal education, maternal smoking, maternal pre-pregnancy BMI, maternal age, and gestational age. DNA methylation measured
in tertiles, comparing low and high methylation to moderate methylation
*p < 0.05. **Statistically significant after Bonferroni correction (p < 0.006)
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between high methylation at the MEG3-IG DMR and
lower birth weight for gestational age z scores in boys
(β = − 0.77; 95% CI − 1.30, − 0.24; p value = 0.005) and be-
tween high methylation at the IGF2 and PEG10 DMRs
and greater birth weight for gestational age z scores in
girls (IGF2: β = 0.58; 95% CI 0.03, 1.12; p value = 0.04;
PEG10: β = 0.63; 95% CI 0.07, 1.20; p value = 0.03).
Discussion
In these analyses, we examined DNA methylation of
nine regulatory regions at birth and anthropometric
measures at birth and age 1 and 3 years. No DMR
showed a consistent association between methylation
and anthropometric z scores at all 3 time points ex-
plored. Our key findings were that high methylation of
the sequences regulating the PEG10 DMR at birth was
associated with a higher age 1-year WFL z score and
3-year BMI z score in boys, low methylation at the
NNAT DMR was associated with higher BMI z scores at
age 3 in girls, and high methylation was associated with
lower WFL z scores at 1 year and BMI z scores at 3 years.
These associations persisted after excluding SGA infants.
Additional findings included associations between
methylation at the PLAGL1 DMR and WFL z scores in
girls at age 1, as well as an association at the IGF2
DMR at age 1 among boys. At age 3, we also observed
an association between methylation at the PEG3 DMR
and BMI z scores in girls. These results suggest that
methylation of imprinted genes at birth is associated
with anthropometric measures at ages 1 and 3 years,
with the PEG10 and NNAT DMRs potentially indicating
an early risk for obesity, and MEST potentially indicat-
ing a lower risk for obesity.
This study adds to a growing body of epidemiologic
evidence on early postnatal growth associated with DNA
methylation at birth and suggests that DNA methylation
at multiple DMRs may be associated with WFL z score
at age 1 year and BMI z score at age 3 years. PLAGL1,
MEST, NNAT, and PEG10 have been associated with
obesity or weight in previous literature. Paternal obesity
has been previously associated with reduced PEG10
transcription in mouse placentas [46]. Our results indi-
cating a higher level of PEG10 methylation is associated
with a greater BMI z score show a similar pattern. Previ-
ous literature has also shown a possible association be-
tween increased MEST expression and inhibition of
adipogenesis [47]. The results of this study echo these
findings, as boys with higher than average methylation
levels had lower BMI z scores. Methylation at the MEST,
NNAT, and PEG10 DMRs has also been previously asso-
ciated with paternal obesity [39], and small and large for
gestational age [48, 49]. In addition, the NNAT gene has
been associated with severe obesity in childhood and
adulthood [50]. Higher methylation at PLAGL1 has also
been associated with maternal obesity [39], and fetal and
postnatal growth [37]. A previous study found a positive
correlation between PLAGL1 methylation and BMI z
scores at age 1 year. PLAGL1 is thought to be an imprint
control region [51]; however, the implications of this in
relation to a potential role in the risk of early obesity are
not yet clear. More research is needed to gain a better
understanding of the relationship between child BMI
and methylation at these DMRs. Previous literature has
supported the role of the IGF2 DMR in fetal growth
[31–34] and birth weight [32, 52], as well as infant
weight gain [32, 36] and child adiposity [35]. We ob-
served an association between IGF2 methylation and
lower BMI z scores; however, this association was not
seen at birth or age 3 years.
We observed sex-specific differences in the associa-
tions between DNA methylation at birth and anthropo-
metric z scores at ages 1 and 3 years. Sex-specific
methylation has been previously observed in relation to
nutrition and other environmental exposures [44, 45,
53], as well as in relation to outcomes, such as small for
gestational age [54]. However, these studies did not find
sex-specific differences in methylation in PEG10, NNAT,
or MEST. This study also adds to the growing literature
on sex-specific DNA methylation.
We conducted additional analysis to explore the influ-
ence of infants who are SGA, as their growth patterns
may differ from those of infants who are not SGA, and
found that SGA may be associated with DNA methyla-
tion. No associations between methylation and BW/GA
z scores remained significant after SGA exclusion, sug-
gesting that SGA may have been driving these associa-
tions. We also found that associations between PEG3
and BMI z scores at both ages 1 and 3 years became sta-
tistically significant after exclusion of SGA infants. This
suggests that perhaps the association between PEG3
methylation and SGA is in the opposite direction of the
association between PEG3 methylation and BMI z scores
for non-SGA infants, thus attenuating the original asso-
ciation. However, a cautious interpretation is warranted,
as exclusion of SGA infants also decreased the statistical
power, which may have led to unstable estimates.
Additional supplemental analysis including only the 166
infants who had non-missing anthropometric values at
all 3 time points showed that many of our associations
remained statistically significant, including our key find-
ings at the PEG10 and NNAT DMRs. This suggests that
these associations were not related to differences in the
samples at each time point. Additional associations
emerged as statistically significant at MEST, IGF2,
PEG10, and NNAT; however, these results must be inter-
preted with caution, as the analysis was underpowered.
Similarly, the results of the supplemental analysis includ-
ing maternal alcohol consumption and the analysis
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stratified by race/ethnicity should be interpreted with
caution, as our sample size was greatly reduced, and esti-
mates may be underpowered.
The direction of the association between higher
methylation at MEST and z scores changed from positive
to negative from birth to ages 1 and 3. The reasons for
this are unclear; however, it is possible that the modest
increase in BW/GA z scores at birth, which we found to
be associated with a higher level of methylation at
MEST, is also associated with a greater likelihood of be-
coming lean as the child grows and becomes more mo-
bile. MEST expression has been previously associated
with obesity in mice [55]; however, a study in humans
found MEST to possibly inhibit adipogenesis [47].
This study benefits from an ethnically diverse cohort,
and prospectively collected data at multiple time points.
This facilitates a better understanding of the timing of
methylation with regard to our outcome of interest,
weight gain. In addition, the use of BMI z scores pro-
vides widely accepted estimate of adiposity that accounts
for a child’s age. However, it is not without limitations.
Our study only included nine DMRs of imprinted genes.
Although these genes were chosen because they have
been linked to growth or chronic disease, it is possible
that important genes have been left out of this study. In
addition, our study’s small sample size may have limited
our ability to see statistically significant differences asso-
ciated with DNA methylation among our population.
Although our analyses were hypothesis driven, multiple
testing is a limitation in this study, as it may increase the
possibility that our results are observed by chance.
However, many associations remained (PEG10, MEST,
PLAGL1, NNAT) even after the stringent Bonferroni
correction. A final limitation was the use of weight sta-
tus instead of weight gain. Much of the literature has
pointed to weight gain in the first year of life as being
associated with later obesity [8]; however, there is some
literature indicating high weight status in early child-
hood as a risk factor for later obesity [56]. It is unclear
whether or not these findings are related to later obesity.
In addition, the results of this study show differences
in anthropometric z scores in association with DNA
methylation that is either lower or higher than the
“average” methylation of our study sample. Notably, the
actual change in continuous methylation associated with
our results is likely small (approximately 1%). However,
even a 1% change in methylation has been previously
shown to result in a doubling or halving of gene expres-
sion at these imprint regulatory regions [45]. Not asses-
sing DNA methylation continuously may be a limitation
of our study, as it creates a challenge in comparing our
results to those of other studies. However, we believe the
results presented in this study may be meaningful for
public health, as it provides a range of methylation
values that may be associated with anthropometric, and
possibly even adiposity.
Conclusions
In summary, our study findings suggest that DNA
methylation of the PLAGL1, MEST, PEG10, and NNAT
DMRs at birth is associated with BMI z scores in early
childhood and varies by sex. Longitudinal assessment of
DNA methylation in these DMRs at older age time
points is needed to determine whether or not methyla-
tion at these DMRs is associated with obesity later in
life. Determining the associations between DNA methy-
lation and early obesity risk is important, as DNA
methylation of regulatory regions may serve as markers
for the assessment of early obesity risk. However, gaining
a better understanding of the exposures that affect
methylation at these regions is also important, as expo-
sures that modify methylation of regions that are associ-
ated with obesity risk may be a good target for early
obesity prevention efforts.
Additional file
Additional file 1: Figure S1. Pyrograms from bisulfite pyrosequencing of
representative samples. Example results from three individual cord blood
specimens are shown for each DMR. The bisulfite-modified version of the
sequence to analyze is shown at the top of each pyrogram, and the
actual sequencing output, by base, is shown at the bottom. Pyrosequencing
is a sequence-by-synthesis method, and the light generated by the
incorporation of each nucleotide (y axis) is proportional to the amount
of the template present in the reaction. For mononucleotides in the
template sequence, a single peak height is generated, but for runs of
two or more of the same nucleotide in the sequence, the peak height
is proportional to that number. Blue diamonds at the top of peaks are
the expected peak height based on the sequence. Orange diamonds in
yellow-brown vertical bars are bisulfite controls, where the original
sequence contains a non-CpG cytosine that should be fully converted
by the bisulfite, and thus, no cytosine signal should be detected at
these positions. There are no diamonds above the potentially methylated
cytosine positions (CGs), which are represented by a “T” position
(for unmethylated cytosine) followed by a “C” position (for methylated cytosines).
These positions are marked by the grey vertical bars, above which shows the
percent methylation for that position of the sequence. (PDF 350 kb)
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